DCGI nod to Sputnik’s single-dose vax for Phase-III trials in India
Earlier in July, the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had refused to grant emergency-use authorisation to Sputnik-Light.
Earlier in July, the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had refused to grant emergency-use authorisation to Sputnik-Light.
"We believe our mRNA platform can solve the world's greatest health challenges, from diseases impacting millions, to ultra-rare diseases impacting dozens, to medicines personalised down to the individual level,"
